MGIA
PFE icon

Matthew Goff Investment Advisor’s Pfizer PFE Stock Holding History

Matthew Goff Investment Advisor’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,640
Closed -$257K – 80
2018
Q1 		$257K Sell
7,640
-700
-8% -$24.1K 0.11% 67
2017
Q4 		$287K Buy
8,340
+69
+0.8% +$2.35K 0.12% 64
2017
Q3 		$280K Sell
8,271
-963
-10% -$31K 0.12% 67
2017
Q2 		$294K Sell
9,234
-2,329
-20% -$73.4K 0.26% 34
2017
Q1 		$375K Buy
+11,563
New +$365K 0.36% 31

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Matthew Goff Investment Advisor's PFE Position: Q2 2018 in Review

Matthew Goff Investment Advisor sold out of Pfizer (PFE) in Q2 2018, closing a stake of 7,640 shares — an estimated $257K sold.

Matthew Goff Investment Advisor first reported a position in PFE in Q1 2017 and held it in 5 quarters. The position peaked at $375K in Q1 2017. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Matthew Goff Investment Advisor reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Matthew Goff Investment Advisor sold 7,640 Pfizer shares in Q2 2018, an estimated $257K.
  • Matthew Goff Investment Advisor first reported a position in Pfizer in Q1 2017 and held it in 5 quarters.
  • Matthew Goff Investment Advisor's Pfizer position peaked at $375K in Q1 2017.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Matthew Goff Investment Advisor's 13F filing for Q2 2018, filed 13 Aug 2018.